Clinical Trials | August 28, 2023
Zydus to present on ZYIL1 at the International Congress of Parkinson's Disease and Movement Disorders
In Phase I studies, ZYIL1 was found to be safe and well-tolerated in human volunteers
In Phase I studies, ZYIL1 was found to be safe and well-tolerated in human volunteers
The drug will be manufactured at JB Pharma's formulation manufacturing facility in Panoli, Gujarat
Rs. 64000 crores are being invested across the 750 districts of India, to create a more resilient healthcare system in the country
Global Initiative on Digital Health launched at the G2O Health Minister’s Meeting
Lupin actively contributes to alleviating the burden of COPD for patients across the nation
Combination creates an integrated provider of drug development and regulatory consulting services serving a complementary client base
Tiotropium (as bromide monohydrate) 18 micrograms powder for inhalation in capsule
Good momentum in commercial CDMO business
First of its kind screening for Glaucoma at grass root level over 10k screened already
Approval to dramatically change CAR-T therapies landscape
Subscribe To Our Newsletter & Stay Updated
